News

Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test

Genalyte Appoints Ashraf Hanna, M.D., Ph.D., as Chief Executive Officer

Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling

Genalyte Expands COVID-19 Antibody Testing To Del Mar Fairgrounds

Genalyte Expands Testing Capabilities to Houston With COVID-19 Antibody Testing

Coronavirus Survivor Determined to Help Others Stricken With Virus

San Diego Blood Bank needs plasma donations from recovered COVID-19 patients

COVID-19’s Impact On Diagnostics